NO20083637L - anvendelse av alkandikarboksylsyrer og retinoider for behandling av rosacea og andre inflammatoriske hudsykdommer - Google Patents
anvendelse av alkandikarboksylsyrer og retinoider for behandling av rosacea og andre inflammatoriske hudsykdommerInfo
- Publication number
- NO20083637L NO20083637L NO20083637A NO20083637A NO20083637L NO 20083637 L NO20083637 L NO 20083637L NO 20083637 A NO20083637 A NO 20083637A NO 20083637 A NO20083637 A NO 20083637A NO 20083637 L NO20083637 L NO 20083637L
- Authority
- NO
- Norway
- Prior art keywords
- rosacea
- treatment
- skin diseases
- inflammatory skin
- retinoids
- Prior art date
Links
- 201000004624 Dermatitis Diseases 0.000 title abstract 2
- 241001303601 Rosacea Species 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title abstract 2
- 201000004700 rosacea Diseases 0.000 title abstract 2
- 150000007513 acids Chemical class 0.000 title 1
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000004492 retinoid derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
For å gjøre tilgjengelig en annen mulighet for behandling av rosacea foreslås anvendelse av minst én a,?-n-alkandikarboksylsyre med 7 til 13 karbonatomer eller estere av denne og minst ett retinoid for fremstilling av et farmasøytisk preparat. Den foreslåtte utformingen er også effektiv ved behandling av andre inflammatoriske hudsykdommer som psoriasis, atopisk dermatitt og alminnelig akne.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76095206P | 2006-01-23 | 2006-01-23 | |
DE102006004804A DE102006004804A1 (de) | 2006-01-23 | 2006-01-23 | Verwendung von Alkandicarbonsäuren und Retinoiden zur Behandlung entzündlicher Hauterkrankungen |
PCT/EP2007/000804 WO2007082780A1 (en) | 2006-01-23 | 2007-01-23 | Use of alkanedicarboxylic acids and retinoids for treatment of rosacea and other inflammatory skin diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20083637L true NO20083637L (no) | 2008-10-07 |
Family
ID=38219816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20083637A NO20083637L (no) | 2006-01-23 | 2008-08-22 | anvendelse av alkandikarboksylsyrer og retinoider for behandling av rosacea og andre inflammatoriske hudsykdommer |
Country Status (14)
Country | Link |
---|---|
US (1) | US20110160306A1 (no) |
EP (2) | EP2316444A3 (no) |
JP (1) | JP2009523750A (no) |
KR (1) | KR20080086515A (no) |
CN (1) | CN101370489A (no) |
AU (1) | AU2007207027A1 (no) |
BR (1) | BRPI0707180A2 (no) |
CA (1) | CA2633774A1 (no) |
DE (1) | DE102006004804A1 (no) |
IL (1) | IL191908A0 (no) |
NO (1) | NO20083637L (no) |
RU (1) | RU2008134316A (no) |
SG (1) | SG169332A1 (no) |
WO (1) | WO2007082780A1 (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2201930A1 (en) | 2008-12-23 | 2010-06-30 | Intendis GmbH | Hydrogel composition for the treatment of dermatological disorders |
US20100273756A1 (en) * | 2009-04-27 | 2010-10-28 | Reza Babapour | Adjunctive formulation and methods for palliation of fine wrinkles, mottled hyperpigmentation, tactile roughness of facial skin and related disorders |
DE102010021671A1 (de) | 2010-05-27 | 2011-12-01 | Intendis Gmbh | Azelainsäurehaltige Formulierung mit Pigmentzusatz |
CN103732218A (zh) * | 2011-06-03 | 2014-04-16 | 阿勒根公司 | 类维生素a化合物至皮脂腺的靶向递送 |
RU2500395C1 (ru) * | 2012-12-07 | 2013-12-10 | Закрытое акционерное общество Фармацевтическое научно-производственное предприятие "Ретиноиды" | Мазевая композиция для местного применения с противоугревой фармакологической активностью |
WO2017019951A2 (en) | 2015-07-30 | 2017-02-02 | Curology, Inc. | Compositions amd methods of treating acne and photoaging |
WO2017192928A1 (en) | 2016-05-06 | 2017-11-09 | Albany Medical College | Treatment of rosacea with p38 and erk kinase pathway inhibitors |
WO2021029659A1 (ko) * | 2019-08-12 | 2021-02-18 | 연세대학교 산학협력단 | 에틸바닐린, 수베르산, 티아졸 또는 이의 염을 유효성분으로 포함하는 알러지성 질환 또는 아토피 피부염 예방 또는 치료용 조성물 |
KR102081029B1 (ko) * | 2019-08-12 | 2020-02-25 | 연세대학교 산학협력단 | 수베르산 또는 이의 염을 유효성분으로 포함하는 알러지성 질환 또는 아토피 피부염 예방 또는 치료용 조성물 |
CN114518416B (zh) * | 2020-11-20 | 2024-05-24 | 上海交通大学医学院附属瑞金医院 | 一种判断银屑病对il-17a抗体应答反应及其复发的标志物 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1075741B (it) | 1977-04-19 | 1985-04-22 | Porro Marcella | Composizione per il trattamento di dermatosi iperpigmentarie |
US4661519A (en) * | 1983-04-12 | 1987-04-28 | Pola Chemical Industries Inc. | Method for dermatological application |
US5326790A (en) * | 1986-11-19 | 1994-07-05 | Dermatologic Research Corporation | Administration of skin medications by use of dicarboxylic acids and derivatives |
DE3811081A1 (de) | 1988-03-30 | 1989-10-12 | Schering Ag | Verwendung von topisch applizierbaren praeparaten zur behandlung der altershaut |
IT1242478B (it) | 1990-02-20 | 1994-03-17 | Schering Spa | Composizioni farmaceutiche ad attivita' depigmentante e contro il danneggiamento cutaneo fotoindotto. |
FR2714602B1 (fr) * | 1993-12-30 | 1996-02-09 | Oreal | Composition antiacnéique pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation. |
JP2001509137A (ja) * | 1996-11-12 | 2001-07-10 | タマーキン ファーマシューティカル イノベイション リミテッド | 皮膚疾患の治療方法 |
CN1091371C (zh) | 1996-12-26 | 2002-09-25 | 苏洪国 | 换肤粉刺霜 |
SE9801647D0 (sv) * | 1998-05-12 | 1998-05-12 | Interhealth Ab | Therapeutic composition |
US20030077301A1 (en) * | 1999-12-16 | 2003-04-24 | Maibach Howard I. | Topical pharmaceutical composition for the treatment of inflammatory dermatoses |
US6358541B1 (en) * | 2000-05-03 | 2002-03-19 | David S. Goodman | Topical preparation for the treatment of hair loss |
GB0128052D0 (en) * | 2001-11-22 | 2002-01-16 | Drug Discovery Lab As | Compounds |
US20050205086A1 (en) * | 2002-10-25 | 2005-09-22 | Foamix Ltd. | Retinoid immunomodulating kit and composition and uses thereof |
US7328924B2 (en) * | 2003-12-12 | 2008-02-12 | Phd, Inc. | Adjustable tip assembly |
US20050169948A1 (en) * | 2004-01-29 | 2005-08-04 | Bernstein Joel E. | Method and compositions for treatment of acne vulgaris and acne rosacea |
ITBS20040068A1 (it) * | 2004-05-24 | 2004-08-24 | Gen Topics Srl | Composizione cosmetica e/o farmaceutica per il trattamento della rosacea |
-
2006
- 2006-01-23 DE DE102006004804A patent/DE102006004804A1/de not_active Ceased
-
2007
- 2007-01-23 JP JP2008550704A patent/JP2009523750A/ja active Pending
- 2007-01-23 EP EP11155163A patent/EP2316444A3/en not_active Withdrawn
- 2007-01-23 US US12/161,706 patent/US20110160306A1/en not_active Abandoned
- 2007-01-23 BR BRPI0707180-9A patent/BRPI0707180A2/pt not_active IP Right Cessation
- 2007-01-23 CN CNA2007800029173A patent/CN101370489A/zh active Pending
- 2007-01-23 EP EP07703154A patent/EP1976499A1/en not_active Withdrawn
- 2007-01-23 WO PCT/EP2007/000804 patent/WO2007082780A1/en active Application Filing
- 2007-01-23 KR KR1020087017927A patent/KR20080086515A/ko not_active Application Discontinuation
- 2007-01-23 AU AU2007207027A patent/AU2007207027A1/en not_active Abandoned
- 2007-01-23 CA CA002633774A patent/CA2633774A1/en not_active Abandoned
- 2007-01-23 SG SG201100390-2A patent/SG169332A1/en unknown
- 2007-01-23 RU RU2008134316/15A patent/RU2008134316A/ru not_active Application Discontinuation
-
2008
- 2008-06-03 IL IL191908A patent/IL191908A0/en unknown
- 2008-08-22 NO NO20083637A patent/NO20083637L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1976499A1 (en) | 2008-10-08 |
JP2009523750A (ja) | 2009-06-25 |
AU2007207027A1 (en) | 2007-07-26 |
US20110160306A1 (en) | 2011-06-30 |
RU2008134316A (ru) | 2010-02-27 |
KR20080086515A (ko) | 2008-09-25 |
CN101370489A (zh) | 2009-02-18 |
IL191908A0 (en) | 2009-08-03 |
EP2316444A2 (en) | 2011-05-04 |
CA2633774A1 (en) | 2007-07-26 |
EP2316444A3 (en) | 2011-06-01 |
SG169332A1 (en) | 2011-03-30 |
WO2007082780A1 (en) | 2007-07-26 |
DE102006004804A1 (de) | 2007-07-26 |
BRPI0707180A2 (pt) | 2011-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20083637L (no) | anvendelse av alkandikarboksylsyrer og retinoider for behandling av rosacea og andre inflammatoriske hudsykdommer | |
Karagounis et al. | Use of “natural” oils for moisturization: Review of olive, coconut, and sunflower seed oil | |
Tanghetti et al. | A current review of topical benzoyl peroxide: new perspectives on formulation and utilization | |
NZ618734A (en) | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas | |
ECSP19025350A (es) | Anticuerpos monoclonales optimizados contra el inhibidor de la vía del factor tisular (tfpi) | |
SG10201400685SA (en) | Use Of Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia | |
AR075423A1 (es) | Composicion farmaceutica que comprende un inhibidor de sglt-2, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y sus usos | |
EA201290108A1 (ru) | Составы в виде везикул | |
RU2008108973A (ru) | Эмульсия типа масло-в-воде для топического нанесения в дерматологии | |
BR112012018256A8 (pt) | método de tratamento de doença de parkinson | |
WO2009091538A3 (en) | Pharmaceutical composition comprising epa and dha for treating hypertriglyceridemia and hypercholesterolemia | |
BRPI0510370A (pt) | derivados de ácido fenoxi-alquil-carboxìlico no tratamento de doenças inflamatórias | |
BRPI0919020A2 (pt) | Uso de células de linhagem monocitária enriquecidas para tratar isquemia e para tratar angina pectoris | |
WO2012163928A3 (en) | Topical wash composition for use in acne patients | |
WO2009022338A3 (en) | Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications | |
JP2014527024A5 (no) | ||
BR112014005546A2 (pt) | ácidos graxos ômega para tratamento de doenças | |
EA200700044A1 (ru) | Композиция для местного применения | |
ITBS20010111A1 (it) | Composizione per uso topico a base dell'estere etilico dell'acido linoleico e e del trietil estere dell'acido citrico associati con opportun | |
RU2007135881A (ru) | Композиция для снижения экссудации белков сыворотки | |
UA112418C2 (uk) | Терапевтичний болезаспокійливий засіб | |
US20150093445A1 (en) | Formulations and methods for treatment of acne and inflammatory skin conditions | |
RU2014102494A (ru) | Ретиноидные композиции местного применения и способы лечения состояний кожи | |
BR112015027569A2 (pt) | compostos, composições, métodos e respectivos usos para tratar doenças por meio da inibição da atividade de tgf-ß | |
US20210052527A1 (en) | N-bromotaurine solutions and emulsions against abnormal cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |